id,indicator_code,spatial_dim_type,iso_code,region_code,time_dim_type,region,dim1type,dim1,year,dim2type,dim2,dim3type,dim3,data_source_dim_type,data_source_dim,value,numeric_value,low,high,comments,date,time_dimension_value,time_dimension_begin,time_dimension_end,country,indicator_name,language,title
8716911,GASPRSCFM,COUNTRY,PER,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3952374,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,5.45,5.45455,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2276671,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,4.17,4.16667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6777674,GASPRSCFM,COUNTRY,DOM,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominican Republic,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2638752,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,50,50,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7367377,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,1.8,1.8018,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3525102,GASPRSCFM,COUNTRY,ECU,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ecuador,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4662428,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0.54,0.54452,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7918186,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
516788,GASPRSCFM,COUNTRY,PRY,AMR,YEAR,Americas,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Paraguay,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2518307,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,3.8,3.8,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4852488,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,2.5,2.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3265227,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
174623,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7873800,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2015,NA,NA,NA,NA,NA,NA,1.91,1.90931,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6524851,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,6.42,6.42202,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7526101,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,3.64,3.63636,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5105727,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,15.24,15.2381,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5444042,GASPRSCFM,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6866779,GASPRSCFM,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Thailand,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
288744,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9727847,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,3.7,3.7037,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5206765,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4497998,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7791432,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8604723,GASPRSCFM,COUNTRY,URY,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7057259,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0.43,0.4347,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6847898,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6917746,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,7.69,7.69231,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3189750,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6417446,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,1.56,1.5625,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1113178,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,1.92,1.92308,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8146793,GASPRSCFM,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,11.11,11.11111,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Croatia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4396622,GASPRSCFM,COUNTRY,LKA,SEAR,YEAR,South-East Asia,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sri Lanka,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3221390,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1706901,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,3.15,3.15315,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1884328,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,1.64,1.64384,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9879528,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3430659,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,1.01,1.0101,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4738744,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,15.84,15.84158,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9361283,GASPRSCFM,COUNTRY,UGA,AFR,YEAR,Africa,NA,NA,2011,NA,NA,NA,NA,NA,NA,0.66,0.66225,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Uganda,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3544710,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,1.2,1.2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1454439,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,13.21,13.20755,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6158286,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9051830,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
384096,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,25,25,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5156416,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8567391,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5899720,GASPRSCFM,COUNTRY,UKR,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6715487,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,10.19,10.18519,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5004781,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9026574,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1840150,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8349734,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8706335,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,1.39,1.38889,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1707280,GASPRSCFM,COUNTRY,MUS,AFR,YEAR,Africa,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Mauritius,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7571169,GASPRSCFM,COUNTRY,RUS,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Russian Federation,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1618867,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2569899,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,7.62,7.61905,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1258119,GASPRSCFM,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Pakistan,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5312301,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2703168,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2013,NA,NA,NA,NA,NA,NA,0.4,0.4037,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6861131,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,11.11,11.11111,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7343042,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2207864,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5024108,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
714101,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,3.4,3.4,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10038254,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4080347,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2011,NA,NA,NA,NA,NA,NA,4.17,4.16667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7165472,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5811357,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4264212,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5577541,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,3.57,3.57143,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8792984,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,5.66,5.66038,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7722851,GASPRSCFM,COUNTRY,CHL,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7785943,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2563850,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7811431,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0.86,0.85837,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3393232,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6108507,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1245882,GASPRSCFM,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,16.67,16.66667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
30730,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8122601,GASPRSCFM,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Luxembourg,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7172144,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,6.52,6.52174,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2519630,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,3.85,3.84615,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7482823,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3304602,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,4.55,4.54545,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
505434,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,2.4,2.39521,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1012545,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5723114,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0.92,0.91743,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1752236,GASPRSCFM,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6329826,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,1.82,1.81818,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5037264,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7710598,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,14.77,14.77273,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3336506,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,5.88,5.88235,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6475711,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,2.2,2.2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7754984,GASPRSCFM,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Thailand,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5012017,GASPRSCFM,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1.9,1.9,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2214892,GASPRSCFM,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Croatia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7527623,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,4.55,4.54545,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8154365,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0.29,0.2907,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9786235,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,4.46,4.46429,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7830941,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,1.8,1.8018,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6627655,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4334706,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3431925,GASPRSCFM,COUNTRY,ROU,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Romania,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5780373,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2418400,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,13.4,13.40206,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5572295,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10127246,GASPRSCFM,COUNTRY,CHL,AMR,YEAR,Americas,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Chile,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6590225,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2016,NA,NA,NA,NA,NA,NA,0.32,0.32344,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10007615,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,2.79,2.78884,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8173473,GASPRSCFM,COUNTRY,UKR,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8173488,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,1.37,1.36986,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2912692,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1.5,1.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5900975,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,5.71,5.71429,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4556662,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2798989,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2009,NA,NA,NA,NA,NA,NA,0.8,0.79929,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6862205,GASPRSCFM,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,India,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8688501,GASPRSCFM,COUNTRY,IDN,SEAR,YEAR,South-East Asia,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Indonesia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4594925,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2013,NA,NA,NA,NA,NA,NA,1.75,1.75274,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9590463,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3818554,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5597587,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2014,NA,NA,NA,NA,NA,NA,1.1,1.10265,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1335236,GASPRSCFM,COUNTRY,BRA,AMR,YEAR,Americas,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brazil,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10070726,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9950949,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4391956,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,12.28,12.2807,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3223110,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3432345,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4461794,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,8.08,8.08081,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1676918,GASPRSCFM,COUNTRY,RUS,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Russian Federation,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1525367,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2773921,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5294627,GASPRSCFM,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,1.11,1.11111,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Czechia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7110052,GASPRSCFM,COUNTRY,PAN,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Panama,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3014338,GASPRSCFM,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Argentina,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6818137,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,6.42,6.42202,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5497060,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9047202,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3755669,GASPRSCFM,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2266446,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3318296,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8104588,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,7.69,7.69231,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8307018,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,5.6,5.6,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
734504,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2539689,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2717429,GASPRSCFM,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2108032,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9825075,GASPRSCFM,COUNTRY,ISR,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Israel,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7465016,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5051046,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,15.8,15.8,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9041067,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2139671,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,5.5,5.50459,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
360812,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,3.26,3.25581,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
89107,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,2.56,2.5641,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3553146,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7686341,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9401576,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2010,NA,NA,NA,NA,NA,NA,3.3,3.29966,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
487751,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6958220,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8142843,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,1.12,1.1236,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
842704,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7851152,GASPRSCFM,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,South Africa,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8423526,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
760313,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,3.03,3.0303,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2635353,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7300559,GASPRSCFM,COUNTRY,KGZ,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Kyrgyzstan,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2919956,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4918668,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6616172,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,1.5,1.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3293458,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
842788,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6964686,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9831907,GASPRSCFM,COUNTRY,COL,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Colombia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10103413,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9445844,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5108562,GASPRSCFM,COUNTRY,CUB,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cuba,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4342344,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6692392,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,14.67,14.66667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
798652,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,36.28,36.28319,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5699781,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,2.9,2.9,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4602325,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,12.14,12.14286,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1203171,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,2.73,2.72727,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3914013,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,2.22,2.22222,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3667538,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5314585,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5364986,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2016,NA,NA,NA,NA,NA,NA,0.31,0.30851,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
722679,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5934139,GASPRSCFM,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,5.6,5.6,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4551642,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,2.63,2.63158,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3924518,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7237591,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,6.36,6.36364,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3629705,GASPRSCFM,COUNTRY,DOM,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominican Republic,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
590056,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6654722,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,7.14,7.14286,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7548442,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,5.5,5.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3579283,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2012,NA,NA,NA,NA,NA,NA,0.09,0.09099,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5523332,GASPRSCFM,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2806805,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,4.67,4.6729,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9219336,GASPRSCFM,COUNTRY,UGA,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0.003,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4190640,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1248140,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,4.8,4.8,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8495263,GASPRSCFM,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,South Africa,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1203681,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2014,NA,NA,NA,NA,NA,NA,0.75,0.74612,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8928147,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4811715,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3832854,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2598108,GASPRSCFM,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5504558,GASPRSCFM,COUNTRY,UKR,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ukraine,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9162449,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,1.3,1.2987,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8112315,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
40008,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,15.13,15.12605,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
103538,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,6.36,6.36364,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
173655,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,15.13,15.12605,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
184995,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
402196,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,1.22,1.21951,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
407019,GASPRSCFM,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
414155,GASPRSCFM,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
502939,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2012,NA,NA,NA,NA,NA,NA,2.24,2.23979,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
541008,GASPRSCFM,COUNTRY,ZWE,AFR,YEAR,Africa,NA,NA,2010,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Zimbabwe,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
553503,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
921922,GASPRSCFM,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,5.56,5.55556,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1035879,GASPRSCFM,COUNTRY,MWI,AFR,YEAR,Africa,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malawi,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1053351,GASPRSCFM,COUNTRY,PRY,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Paraguay,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1180192,GASPRSCFM,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,NA,2016,NA,NA,NA,NA,NA,NA,6.33,6.32911,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,India,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1407720,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1427504,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,5.45,5.45455,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1845420,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0.8,0.8,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2015059,GASPRSCFM,COUNTRY,SLV,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,El Salvador,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2033434,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,0.83,0.83333,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2071803,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,8.33,8.33333,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2091027,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,25.45,25.45455,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2280639,GASPRSCFM,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2287370,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2581007,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2676175,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,18.57,18.57143,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2756837,GASPRSCFM,COUNTRY,KEN,AFR,YEAR,Africa,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Kenya,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2781832,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2896129,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,5.19,5.19481,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3054416,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3055412,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,2.78,2.77778,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3296348,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0.9,0.9,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3346387,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0.99,0.9901,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3523767,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,6.33,6.32911,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3535614,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3605705,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2015,NA,NA,NA,NA,NA,NA,0.49,0.48572,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3750949,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3957100,GASPRSCFM,COUNTRY,PER,AMR,YEAR,Americas,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Peru,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3988915,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1.3,1.3,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4008127,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4090084,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,4.26,4.25532,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4222959,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,12.87,12.87129,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4299550,GASPRSCFM,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4572572,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,11.93,11.92661,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4605085,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,8.51,8.51064,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4616071,GASPRSCFM,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,South Africa,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4710755,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,6.5,6.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4843875,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4862945,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4883639,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4970878,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,2.2,2.20264,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4995844,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5020668,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5067075,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5179332,GASPRSCFM,COUNTRY,CUB,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cuba,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5246209,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5310872,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5435716,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,2.07,2.06897,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5449021,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,22.73,22.72727,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5492306,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,3.64,3.63636,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5650315,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5784334,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5853501,GASPRSCFM,COUNTRY,UGA,AFR,YEAR,Africa,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6137498,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6163516,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,1.4,1.4,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6339339,GASPRSCFM,COUNTRY,KEN,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6364830,GASPRSCFM,COUNTRY,BTN,SEAR,YEAR,South-East Asia,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Bhutan,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6440142,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,6.82,6.81818,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6522815,GASPRSCFM,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6555784,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6567096,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6573509,GASPRSCFM,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,NA,2018,NA,NA,NA,NA,NA,NA,4.21,4.21053,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6649774,GASPRSCFM,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,1.1,1.1,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6744591,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6776394,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,3.13,3.125,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6813847,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0.9,0.9,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6997343,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7042719,GASPRSCFM,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7081140,GASPRSCFM,COUNTRY,ECU,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ecuador,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7112070,GASPRSCFM,COUNTRY,KEN,AFR,YEAR,Africa,NA,NA,2010,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Kenya,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7118943,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0.68,0.6812,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7175455,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,0.88,0.87719,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7200720,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7207976,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7219307,GASPRSCFM,COUNTRY,MMR,SEAR,YEAR,South-East Asia,NA,NA,2016,NA,NA,NA,NA,NA,NA,66.67,66.66667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Myanmar,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7245983,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7467371,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2011,NA,NA,NA,NA,NA,NA,0.13,0.12804,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7739427,GASPRSCFM,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2015,NA,NA,NA,NA,NA,NA,0.14,0.13736,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Argentina,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7808686,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,1.83,1.83486,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7878023,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2009,NA,NA,NA,NA,NA,NA,1.13,1.12685,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8209459,GASPRSCFM,COUNTRY,PER,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8278465,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8291693,GASPRSCFM,COUNTRY,COL,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Colombia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8297703,GASPRSCFM,COUNTRY,ROU,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,15.38,15.38462,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Romania,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8391224,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2009,NA,NA,NA,NA,NA,NA,21.15,21.15385,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8459187,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,0.93,0.93458,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8595599,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2012,NA,NA,NA,NA,NA,NA,3.75,3.75,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8673494,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0.42,0.41841,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8949582,GASPRSCFM,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8973086,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9100373,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,NA,2011,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9529609,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9612144,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2013,NA,NA,NA,NA,NA,NA,11.82,11.81818,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9764740,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2010,NA,NA,NA,NA,NA,NA,20.83,20.83333,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9790244,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9801741,GASPRSCFM,COUNTRY,UKR,EUR,YEAR,Europe,NA,NA,2015,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ukraine,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9882884,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,NA,2014,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9903687,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,22.2,22.2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9923027,GASPRSCFM,COUNTRY,PRY,AMR,YEAR,Americas,NA,NA,2016,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Paraguay,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10049224,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,NA,2010,NA,NA,NA,NA,NA,NA,0.14,0.14052,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10116639,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
